A small but statistically significant difference was observed in the median unadjusted levodopa equivalent daily dose at baseline between women ( 300 mg ) and men ( 325 mg ) , but this was not observed after controlling for disease duration ( years since Parkinson disease diagnosis ) , disease severity ( Unified Parkinson 's Disease Rating Scale Motor and Activities of Daily Living Scores ) , and body weight .